Abstract:HistopathologyVolume 52, Issue 2 p. 247-250 Mutant L Homologue 1 (MLH1): a possible new immunohistochemical marker for prostatic cancer S-T Chuang, S-T Chuang Departments of PathologySearch for more papers by this authorB Adley, B Adley Departments of PathologySearch for more papers by this authorM Han, M Han Urology, Northwestern University Feinberg School of Medicine, Chicago, ILSearch for more papers by this authorF Lin, F Lin Department of Pathology, Geisinger Medical Center, Danville, PA, USASearch for more papers by this authorX J Yang, X J Yang Departments of Pathology Urology, Northwestern University Feinberg School of Medicine, Chicago, ILSearch for more papers by this authorW J Catalona, W J Catalona Urology, Northwestern University Feinberg School of Medicine, Chicago, ILSearch for more papers by this author S-T Chuang, S-T Chuang Departments of PathologySearch for more papers by this authorB Adley, B Adley Departments of PathologySearch for more papers by this authorM Han, M Han Urology, Northwestern University Feinberg School of Medicine, Chicago, ILSearch for more papers by this authorF Lin, F Lin Department of Pathology, Geisinger Medical Center, Danville, PA, USASearch for more papers by this authorX J Yang, X J Yang Departments of Pathology Urology, Northwestern University Feinberg School of Medicine, Chicago, ILSearch for more papers by this authorW J Catalona, W J Catalona Urology, Northwestern University Feinberg School of Medicine, Chicago, ILSearch for more papers by this author First published: 13 November 2007 https://doi.org/10.1111/j.1365-2559.2007.02879.xRead the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Burmester JK, Suarez BK, Lin JH et al. Analysis of candidate genes for prostate cancer. Hum. Hered. 2004; 57; 172–178. 10.1159/000081443 CASPubMedWeb of Science®Google Scholar 2 Strand M, Prolla TA, Liskay RM, Petes TD. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 1993; 365; 274–276. 10.1038/365274a0 CASPubMedWeb of Science®Google Scholar 3 Cunningham JM, Shan A, Wick MJ et al. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res. 1996; 56; 4475–4482. CASPubMedWeb of Science®Google Scholar 4 Egawa S, Uchida T, Suyama K et al. Genomic instability of microsatellite repeats in prostate cancer: relationship to clinicopathological variables. Cancer Res. 1995; 55; 2418–2421. CASPubMedWeb of Science®Google Scholar 5 Gao X, Wu N, Grignon D et al. High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene 1994; 9; 2999–3003. CASPubMedWeb of Science®Google Scholar 6 Yeh CC, Lee C, Dahiya R. DNA mismatch repair enzyme activity and gene expression in prostate cancer. Biochem. Biophys. Res. Commun. 2001; 285; 409–413. 10.1006/bbrc.2001.5187 CASPubMedWeb of Science®Google Scholar 7 Chen Y, Wang J, Fraig MM et al. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer. Int. J. Oncol. 2003; 22; 1033–1043. CASPubMedWeb of Science®Google Scholar 8 Chen Y, Wang J, Fraig MM et al. Defects of DNA mismatch repair in human prostate cancer. Cancer Res. 2001; 61; 4112–4121. CASPubMedWeb of Science®Google Scholar 9 Caldes T, Godino J, Sanchez A et al. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Oncol Rep. 2004; 12; 621–629. CASPubMedWeb of Science®Google Scholar Volume52, Issue2January 2008Pages 247-250 ReferencesRelatedInformation

Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search

A Genetic Study and Meta-Analysis of the Genetic Predisposition of Prostate Cancer in a Chinese Population

Mutant L Homologue 1 (MLH1): a Possible New Immunohistochemical Marker for Prostatic Cancer

Evidence for a prostate cancer susceptibility locus on the X chromosome.

Prostate Cancer Risk Locus at 8q24 As a Regulatory Hub by Physical Interactions with Multiple Genomic Loci Across the Genome.

A candidate prostate cancer susceptibility gene at chromosome 17p

A Meta-Analysis of 87,040 Individuals Identifies 23 New Susceptibility Loci for Prostate Cancer.

Genome-wide Association Study in Chinese Men Identifies Two New Prostate Cancer Risk Loci at 9q31.2 and 19Q13.4.

Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men

Chromatin Interactions and Candidate Genes at Ten Prostate Cancer Risk Loci.

Uncovering Somatic Genetic Susceptibility Factors in Prostate Cancer Through Comprehensive Genome-Wide Analysis

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

A Large Multiethnic Genome-Wide Association Study of Prostate Cancer Identifies Novel Risk Variants and Substantial Ethnic Differences

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31. 2 and 19q13. 4

Large-scale Association Analysis in Asians Identifies New Susceptibility Loci for Prostate Cancer

Genome-wide Association Scan for Variants Associated with Early-Onset Prostate Cancer.

Genome-wide Germline Correlates of the Epigenetic Landscape of Prostate Cancer

Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases

Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry